Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05520411 · ClinicalTrials.gov registry record · NA
Examining the Effectiveness of Digestive Enzymes at Reducing Bloating and Stomach Distension
A NA study, sponsored by HUM Nutrition.
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT05520411: Completed NA study, sponsored by HUM Nutrition.
NCT05520411 is a NA study that has completed, run by HUM Nutrition. The registered enrollment target is 25 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05520411, a NA study, has completed, sponsored by HUM Nutrition.
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
Flatter Me is a product that includes digestive enzymes in a way to support digestion of macronutrients and their constituents and provides herbs traditionally used for digestive health support. This trial aims to test Flatter Me against a placebo pill to examine differences in both subjective outcomes (feelings of bloating and indigestion) and changes in waist circumference (abdominal distension) after eating a test meal.
Primary Outcome
Questionnaires will be administered to participants at multiple time points before and after eating a test meal. Symptom severity is rated on a scale of 0 (None) to 4 (Extremely Severe)
Interventions
- DIETARY_SUPPLEMENT HUM Flatter Me
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2022-07-01 |
| Est. Completion | 2023-01-15 |
| Phase | NA |
What the finished NCT05520411 record still lists
NCT05520411 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which HUM Flatter Me is the first listed.
NCT05520411 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05520411 about?
NCT05520411 is a clinical study titled "Examining the Effectiveness of Digestive Enzymes at Reducing Bloating and Stomach Distension". Flatter Me is a product that includes digestive enzymes in a way to support digestion of macronutrients and their constituents and provides herbs traditionally used for digestive health support. This trial aims to test Flatter Me against a placebo pill to examine differences in both subjective outco...
What is the current status of trial NCT05520411?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2022-07-01. Estimated completion is 2023-01-15.
What interventions are being tested in trial NCT05520411?
The interventions under investigation include: HUM Flatter Me (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05520411?
This trial is sponsored by HUM Nutrition, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05520411's enrollment target sits among peer trials
25 1712th of 2000 higher than 265 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI